Physician-Guided Weight Management
Explore medically supervised weight-management options designed around your health history, goals, and individual needs.
Programs
Weight Management
Physician-Guided Weight Management
$179/month
Consultation + Shipping Included
Includes 2-day shipping of prescribed medication.
Lab testing may be separate when required.
Semaglutide is a GLP-1 receptor agonist that may be considered as part of an individualized, medically supervised weight-management plan.
Weight Management
Physician-Guided Weight Management
$249/month
Consultation + Shipping Included
Includes 2-day shipping of prescribed medication.
Lab testing may be separate when required.
Tirzepatide acts on both GIP and GLP-1 receptors and may be considered for certain eligible patients as part of a medically supervised weight-management plan.
Important Information
The semaglutide and tirzepatide offered through Top Tier TRT are prescription compounded medications. Treatment is available only if a licensed medical provider determines it is appropriate after an individual evaluation.
The semaglutide and tirzepatide offered through Top Tier TRT are compounded medications prepared by a licensed 503A compounding pharmacy for an individual patient pursuant to a valid prescription. These compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before marketing. Compounded medications are not generic versions of, or equivalent to, FDA-approved products.
Eligibility, medication selection, dosing, and monitoring are determined individually. Results vary, and no specific amount of weight loss is guaranteed.
Understanding Care
Lasting change depends on more than medication. A thoughtful plan looks at the whole person.
Results vary. No specific amount of weight loss is guaranteed.
Education
GLP-1 receptor agonist
Semaglutide mimics GLP-1, a hormone the body releases after eating. It acts on GLP-1 receptors involved in appetite regulation and slows how quickly the stomach empties, which may help some patients feel full sooner and reduce food intake. Responses vary from person to person.
Dual GIP and GLP-1 receptor agonist
Tirzepatide acts on two incretin hormone pathways — GIP and GLP-1 — that are involved in appetite, satiety, and how the body handles glucose. Activity at both receptors may influence appetite and food intake in some patients. Responses vary from person to person.
Comparison
An educational overview. Neither medication is right for everyone, and one is not automatically better than the other.
| Semaglutide | Tirzepatide | |
|---|---|---|
| Medication class | GLP-1 receptor agonist | Dual GIP / GLP-1 receptor agonist |
| How it works | Acts on GLP-1 receptors involved in appetite and stomach emptying | Acts on both GIP and GLP-1 receptors involved in appetite and satiety |
| Medical evaluation | Required — health history, medications, contraindications, testing as needed | Required — health history, medications, contraindications, testing as needed |
| Treatment decision | Individualized by a licensed provider | Individualized by a licensed provider |
| Ongoing monitoring | Regular follow-ups on progress, side effects, and dosing | Regular follow-ups on progress, side effects, and dosing |
| Safety considerations | GI side effects; boxed thyroid C-cell tumor warning; pancreatitis, gallbladder, kidney risks | GI side effects; boxed thyroid C-cell tumor warning; pancreatitis, gallbladder, kidney risks; may reduce oral birth control effectiveness |
Eligibility
Not everyone qualifies. Eligibility may depend on:
At-Home Testing
For eligible testing requirements, Top Tier TRT offers at-home blood testing kits delivered to your door. Whether lab work is needed — and which tests — depends on your individual medical needs and your provider's guidance.
Some patients may need to visit a lab instead. Lab testing may be separate when required.
How It Works
01
Complete Your Wellness Assessment
02
Complete Your Medical Intake and Required Testing
03
Receive Licensed Provider Evaluation
04
Discuss Your Individualized Care Plan
05
Receive Ongoing Monitoring and Support
Medication is provided only if prescribed following an appropriate evaluation.
Safety & Medical Oversight
GLP-1-related treatment requires an individualized risk assessment and ongoing medical follow-up. This is not a complete list — your provider reviews all risks with you.
Pricing
Weight Management
Physician-Guided Weight Management
$179/month
Consultation + Shipping Included
Includes 2-day shipping of prescribed medication.
Lab testing may be separate when required.
Semaglutide is a GLP-1 receptor agonist that may be considered as part of an individualized, medically supervised weight-management plan.
Recurring monthly program. Cancel anytime per our cancellation policy. Treatment is subject to medical evaluation and provider approval; payment does not guarantee a prescription or medication.
Weight Management
Physician-Guided Weight Management
$249/month
Consultation + Shipping Included
Includes 2-day shipping of prescribed medication.
Lab testing may be separate when required.
Tirzepatide acts on both GIP and GLP-1 receptors and may be considered for certain eligible patients as part of a medically supervised weight-management plan.
Recurring monthly program. Cancel anytime per our cancellation policy. Treatment is subject to medical evaluation and provider approval; payment does not guarantee a prescription or medication.
Prices include the provider consultation and 2-day shipping of prescribed medication. Lab testing may be separate when required. Programs are billed monthly until canceled; cancel anytime by emailing start@toptiertrt.com. Treatment is subject to medical evaluation and provider approval, and payment does not guarantee a prescription or medication.
FAQ
Semaglutide is a GLP-1 receptor agonist. When a licensed provider determines it is medically appropriate, it may be considered as part of an individualized weight-management plan that also includes nutrition and activity guidance.
Tirzepatide acts on both GIP and GLP-1 receptors. It may be considered for certain eligible patients as part of a medically supervised weight-management plan.
Semaglutide acts on GLP-1 receptors, while tirzepatide acts on both GIP and GLP-1 receptors. Neither is right for everyone, and one is not automatically better than the other — your provider considers your health history, goals, and risk factors when discussing options.
A licensed provider reviews weight-related clinical criteria, your health history, current medications, possible contraindications, and relevant testing. Not everyone qualifies, and the provider makes the final decision.
You complete a detailed medical intake and a remote consultation with a licensed provider, who may request laboratory testing before making any treatment decision.
Blood testing may be required depending on your health history and your provider's guidance. Lab testing may be separate from the monthly price when required.
For eligible testing requirements, an at-home blood testing kit may be available. Some patients may need to visit a lab instead.
Common side effects include nausea, vomiting, diarrhea, and constipation. Serious risks can include pancreatitis, gallbladder problems, kidney injury, low blood sugar with certain medications, and a boxed warning about thyroid C-cell tumors. Your provider reviews these with you before any treatment.
If a provider determines treatment is not appropriate, no medication is prescribed. Payments made before your consultation are refunded in full, as described in our cancellation and refund policy.
The monthly price includes the provider consultation and 2-day shipping of prescribed medication. Lab testing may be separate when required.
Your provider schedules follow-up check-ins to review progress, side effects, and whether any adjustment, pause, or stop is appropriate.
Programs are billed monthly until canceled. You can cancel by emailing start@toptiertrt.com. Payment does not guarantee a prescription or medication.
A short, private assessment is the first step. A licensed provider decides whether any treatment is appropriate.
